Final results of the European Advanced Renal Cell Carcinoma Sorafenib (EU-ARCCS) expanded-access study: a large open-label study in diverse community settings

Autor: Beck, J., Procopio, G., Bajetta, E., Keilholz, U., Negrier, S., Szczylik, C., Bokemeyer, C., Bracarda, S., Richel, D.J., Staehler, M., Strauss, U.P., Mersmann, S., Burock, K., Escudier, B. *
Zdroj: In Annals of Oncology August 2011 22(8):1812-1823
Databáze: ScienceDirect